T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...
Jan 16, 2018
0
27